Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors-Reference-Cited by-同舟云学术

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors

Published:2018-12 Issue:1 Volume:12 Page:
ISSN:1752-153X
Container-title:Chemistry Central Journal
language:en
Short-container-title:Chemistry Central Journal

Author:

Gawad Jineetkumar^ORCID,Bonde Chandrakant

Publisher

Springer Science and Business Media LLC

Subject

General Chemistry

Link

http://link.springer.com/content/pdf/10.1186/s13065-018-0515-1.pdf

Reference50 articles.

1. Batt SM, Jabeen T, Bhowruth V, Quill L, Lund PA, Eggeling L (2012) Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinones inhibitors. Proc Natl Acad Sci 109:354–359. https://doi.org/10.1073/pnas.1205735109

2. Riccardi G, Pasca MR, Chiarelli LR, Manina G, Mattevi A, Binda C (2013) The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. Appl Microbiol Biotechnol 97:8841–8848. https://doi.org/10.1007/s00253-013-5218-x

3. Makarov V, Neres J, Hartkoorn RC, Ryabova OB, Kazakova E, Šarkan M (2015) 8-Pyrrole-benzothiazinones non-covalent inhibitors of DprE1 from Mycobacterium tuberculosis. Antimicrob Agents Chemother 59:778–786. https://doi.org/10.1128/AAC.00778-15

4. Scribner A, Dennis R, Lee S, Ouvry G, Perrey D, Fisher M (2008) Synthesis and biological activity of imidazopyridine anticoccidial agents: part II. Eur J Med Chem 43:1123–1151. https://doi.org/10.1016/j.ejmech.2007.02.006

5. Piton J, Foo CSY, Cole ST (2017) Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors. Drug discov today 22:526–533. https://doi.org/10.1016/j.drudis.2016.09.014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling DprE1 as a Key Target in the Fight against Tuberculosis: Insights and Perspectives on Developing Novel Antimicrobial Agents;BioMed;2024-07-25

2. In silico drug design strategies for discovering novel tuberculosis therapeutics;Expert Opinion on Drug Discovery;2024-02-19

3. Imidazo[4,5-b]Pyridines: From Kinase Inhibitors to more Diversified Biological Properties;Current Medicinal Chemistry;2024-02

4. Design, synthesis, biological evaluation and molecular dynamics of some novel 3-phenylpyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione based compounds as anti-tubercular agents;Journal of Biomolecular Structure and Dynamics;2023-09-01

5. Exploring Decaprenylphosphoryl-β-d-Ribose 2′-Epimerase 1 (DprE1): A Target for Anti-tubercular Drugs;Integrated Science;2023